South Korea Companion Animal Healthcare Market, by End User, 2018-2027
| Label | Diagnostic Imaging | Immunodiagnostic Tests | Molecular Diagnostics | Others |
|---|---|---|---|---|
| 2018 | 11.07 USD Mn | 8.76 USD Mn | 5.83 USD Mn | 11.25 USD Mn |
| 2019 | 11.74 USD Mn | 9.43 USD Mn | 6.19 USD Mn | 12 USD Mn |
| 2020 | 12.32 USD Mn | 10.06 USD Mn | 6.51 USD Mn | 12.67 USD Mn |
| 2021 | 13.13 USD Mn | 10.9 USD Mn | 6.96 USD Mn | 13.59 USD Mn |
| 2022 | 14.02 USD Mn | 11.83 USD Mn | 7.44 USD Mn | 14.6 USD Mn |
| 2023 | 15 USD Mn | 12.86 USD Mn | 7.98 USD Mn | 15.71 USD Mn |
| 2024 | 16.07 USD Mn | 14 USD Mn | 8.57 USD Mn | 16.94 USD Mn |
| 2025 | 17.25 USD Mn | 15.27 USD Mn | 9.22 USD Mn | 18.29 USD Mn |
| 2026 | 18.55 USD Mn | 16.68 USD Mn | 9.93 USD Mn | 19.79 USD Mn |
| 2027 | 19.99 USD Mn | 18.26 USD Mn | 10.72 USD Mn | 21.46 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027 portion of the South Korea Companion Animal Healthcare Market, by Diagnostics, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 65 Mn in 2026 and is projected to reach USD 70 Mn by 2027 — a gain of about 8% over the forecast period, translating to a CAGR in the high single digits.
- By 2027, Others is the largest of the 4 groups tracked here, at 21. 46M USD, 30% of the combined total.
- What the regional split looks like (2026): Others leads, holding roughly 30% of segment value — the single largest regional share. Diagnostic Imaging is the second-largest contributor. Immunodiagnostic Tests and Molecular Diagnostics make up the remainder, in descending order.
- By 2027, Others alone is expected to reach USD 21 Mn, with Diagnostic Imaging at USD 20 Mn.
Market Dynamics
By 2027, Others is the largest of the 4 groups tracked here, at 21.46M USD, 30% of the combined total.
Diagnostic Imaging is runner-up at 19.99M USD — 7% off the lead.
Others: 11.25M USD to 21.46M USD, 91% higher by 2027.
Diagnostic Imaging: up 81% over the period, 11.07M USD to 19.99M USD.
Immunodiagnostic Tests grows to 18.26M USD by 2027, from 8.76M USD in 2018 — 108% up.
Molecular Diagnostics climbs from 5.83M USD (2018) to 10.72M USD (2027), a 84% gain.
By rate of change, not size, Immunodiagnostic Tests is the standout — 108% growth, faster than the rest of the group.
Across the full group, the combined total moves from 36.91M USD in 2018 to 70.43M USD in 2027 — a 91% change.
How To Compare These 4 Groups
This chart compares 4 series side by side, not one trend over time. Read them against each other — the biggest number in the room is not automatically the most important line to follow.
The largest series today is not guaranteed to stay largest — check the growth rate of each group, not just its current size, before projecting the ranking forward.
Use this chart to size the South Korea Companion Animal Healthcare market and to compare how fast it is expected to grow against adjacent markets — it works best as an input to a market-entry or investment decision, not as a standalone verdict.
The numbers here come from a market sizing model: historical revenue estimates up to the 2018 base year, then forecasts through 2027 using growth-rate assumptions for each segment. The underlying report explains the methodology in detail.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Charts From Same Market
View AllSouth Korea Companion Animal Healthcare Market, by Pharmaceuticals, 2018-2027
South Korea Companion Animal Healthcare Market, by Feed Additives, 2018-2027
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



